ADVFN Logo
Boards:
    Quotes:
      Boards
      News
      Market Data
      Markets
      Discover
      AI Subscribe Login/Register Profile Icon
      S&P 500
      6,037.88
      0.72%
      US Tech 100
      20,916.80
      0.93%
      Dow Jones
      44,556.04
      0.30%
      Brent Oil
      75.835
      -0.14%
      Bitcoin
      97,663.70
      -0.20%
      Registration Strip Icon for alerts Register for real-time alerts, custom portfolio, and market movers
      Get Started
      1. Home
      2. Investing
      3. Stocks
      4. USA
      5. NASDAQ

      6. Enlivex Therapeutics Ltd (ENLV) Quote

      Enlivex Therapeutics Ltd

      Enlivex Therapeutics Ltd (ENLV)

      NASDAQ
      1.08
      0.00
      (0.00%)
      Closed February 04 4:00PM
      Delayed by 15 minutes
      1.085
      0.005
      (0.46%)
      After Hours: 7:59PM
      Delayed by 15 minutes

      Professional-Grade Tools, for Individual Investors.

      Premium

      Key stats and details

      Current Price
      1.08
      Bid
      1.08
      Ask
      1.13
      Volume
      45,211
      1.05 Day's Range 1.11
      0.8101 52 Week Range 4.59
      Market Cap
      22.55M
      Previous Close
      1.08
      Open
      1.11
      Last Trade
      5
      @
      1.13
      Last Trade Time
      Financial Volume
      $ 48,507
      VWAP
      1.0729
      Average Volume (3m)
      225,288
      Shares Outstanding
      20,880,000
      Dividend Yield
      -
      PE Ratio
      -0.78
      Earnings Per Share (EPS)
      -1.39
      Revenue
      -
      Net Profit
      -29.07M

      About Enlivex Therapeutics Ltd

      Enlivex Therapeutics Ltd is an Israel-based development-stage biopharmaceutical company. It is focused on developing and commercializing an allogeneic drug pipeline for rebalancing immune hyper-responses. The company's Allocetra is an immunotherapy that is being developed to rebalance a life-threate... Enlivex Therapeutics Ltd is an Israel-based development-stage biopharmaceutical company. It is focused on developing and commercializing an allogeneic drug pipeline for rebalancing immune hyper-responses. The company's Allocetra is an immunotherapy that is being developed to rebalance a life-threatening unbalanced immune system, using the immune system's own natural regulation mechanisms. Show more

      Sector
      Pharmaceutical Preparations
      Industry
      Pharmaceutical Preparations
      Website
      www.enlivex.com
      Headquarters
      Ness Ziona, Center, Isr
      Founded
      -
      Enlivex Therapeutics Ltd is listed in the Pharmaceutical Preparations sector of the NASDAQ with ticker ENLV. The last closing price for Enlivex Therapeutics was $1.08. Over the last year, Enlivex Therapeutics shares have traded in a share price range of $ 0.8101 to $ 4.59.

      Enlivex Therapeutics currently has 20,880,000 shares outstanding. The market capitalization of Enlivex Therapeutics is $22.55 million. Enlivex Therapeutics has a price to earnings ratio (PE ratio) of -0.78.

      Ask ADVFN Intelligence (AI)

      ENLV Latest News

      More News

      Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]

      December 11 2024
      Edgar (US Regulatory)

      Enlivex Receives Regulatory Authorization for the Initiation of a Phase I Trial Evaluating Allocetra in Patients with TMJ Osteoarthritis

      Ness-Ziona, Israel, Dec. 11, 2024 (GLOBE NEWSWIRE) -- Enlivex Therapeutics Ltd. (Nasdaq: ENLV, the “Company”), a clinical-stage macrophage reprogramming immunotherapy company, today announced...

      December 11 2024
      GlobeNewswire Inc.

      Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]

      December 03 2024
      Edgar (US Regulatory)

      Enlivex Announces Positive Interim Efficacy Data from Allocetra Trial in Patients with Moderate to Severe Knee Osteoarthritis

      Nes-Ziona, Israel, Dec. 03, 2024 (GLOBE NEWSWIRE) -- Enlivex Therapeutics Ltd. (Nasdaq: ENLV, the “Company”), a clinical-stage macrophage reprogramming immunotherapy company, today announced...

      December 03 2024
      GlobeNewswire Inc.

      Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]

      November 29 2024
      Edgar (US Regulatory)

      Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]

      November 20 2024
      Edgar (US Regulatory)

      Enlivex Adopts Bitcoin Treasury Reserve Strategy

      Nes-Ziona, Israel, Nov. 20, 2024 (GLOBE NEWSWIRE) -- Enlivex Therapeutics Ltd. (Nasdaq: ENLV, the “Company”), a clinical-stage macrophage reprogramming immunotherapy company, today announced...

      November 20 2024
      GlobeNewswire Inc.

      Form SC 13G - Statement of Beneficial Ownership by Certain Investors

      November 14 2024
      Edgar (US Regulatory)

      Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]

      November 14 2024
      Edgar (US Regulatory)

      Enlivex Announces the Dosing of the First Patient in a Phase I Clinical Trial Evaluating Allocetra in Patients with Psoriatic Arthritis

      Nes-Ziona, Israel, Nov. 14, 2024 (GLOBE NEWSWIRE) --  Enlivex Therapeutics Ltd. (Nasdaq: ENLV, the “Company”), a clinical-stage macrophage reprogramming immunotherapy company, today announced...

      November 14 2024
      GlobeNewswire Inc.
      PeriodChangeChange %OpenHighLowAvg. Daily VolVWAP
      1-0.06-5.263157894741.141.151395811.10531344CS
      4-0.1797-14.26530126221.25971.25991662031.15955178CS
      12-0.12-101.21.34650.81012252881.20692783CS
      26-0.18-14.28571428571.261.750.81011597201.30586249CS
      52-1.47-57.64705882352.554.590.81011397131.67957063CS
      156-4.04-78.906255.128.640.8101761212.56571641CS
      260-6.82-86.32911392417.929.40.81011772338.86514625CS

      ENLV - Frequently Asked Questions (FAQ)

      What is the current Enlivex Therapeutics share price?
      The current share price of Enlivex Therapeutics is $ 1.08
      How many Enlivex Therapeutics shares are in issue?
      Enlivex Therapeutics has 20,880,000 shares in issue
      What is the market cap of Enlivex Therapeutics?
      The market capitalisation of Enlivex Therapeutics is USD 22.55M
      What is the 1 year trading range for Enlivex Therapeutics share price?
      Enlivex Therapeutics has traded in the range of $ 0.8101 to $ 4.59 during the past year
      What is the PE ratio of Enlivex Therapeutics?
      The price to earnings ratio of Enlivex Therapeutics is -0.78
      What is the reporting currency for Enlivex Therapeutics?
      Enlivex Therapeutics reports financial results in USD
      What is the latest annual profit for Enlivex Therapeutics?
      The latest annual profit of Enlivex Therapeutics is USD -29.07M
      What is the registered address of Enlivex Therapeutics?
      The registered address for Enlivex Therapeutics is 14 EINSTEIN STREET, NESS ZIONA, CENTER, 7403618
      What is the Enlivex Therapeutics website address?
      The website address for Enlivex Therapeutics is www.enlivex.com
      Which industry sector does Enlivex Therapeutics operate in?
      Enlivex Therapeutics operates in the PHARMACEUTICAL PREPARATIONS sector

      Movers

      View all
      • Most Active
      • % Gainers
      • % Losers
      SymbolPriceVol.
      CAPTCaptiVision Inc
      $ 1.024
      (133.26%)
      		245.99M
      QNTMQuantum Biopharma Ltd
      $ 6.70
      (110.69%)
      		78.56M
      LTRYLottery com Inc
      $ 0.58
      (85.90%)
      		129.21M
      CPIXCumberland Pharmaceutical Inc
      $ 3.7801
      (77.47%)
      		18.49M
      INKTMiNK Therapeutics Inc
      $ 12.08
      (53.69%)
      		350.86k
      OMGAOmega Therapeutics Inc
      $ 0.1473
      (-69.25%)
      		11.7M
      VIRXViracta Therapeutics Inc
      $ 0.0352
      (-54.76%)
      		6.33M
      CYNCYNGN Inc
      $ 0.0708
      (-39.44%)
      		137.27M
      UPCUniverse Pharmaceuticals Inc
      $ 0.2663
      (-36.20%)
      		1.9M
      CSAICloudastructure Inc
      $ 12.98
      (-31.68%)
      		57.03k
      NVDANVIDIA Corporation
      $ 118.65
      (1.71%)
      		256.77M
      CAPTCaptiVision Inc
      $ 1.024
      (133.26%)
      		245.99M
      PLTRPalantir Technologies Inc
      $ 103.83
      (23.99%)
      		230.5M
      RGTIRigetti Computing Inc
      $ 13.71
      (1.78%)
      		159.63M
      TNXPTonix Pharmaceuticals Holding Corporation
      $ 0.1518
      (-22.11%)
      		142.77M

      ENLV Discussion

      View Posts
      redspinelpinktopaz redspinelpinktopaz 2 months ago
      They're advertising on CNBC. What's that all about?
      👍️0
      glenn1919 glenn1919 2 months ago
      enlv...................................https://stockcharts.com/h-sc/ui?s=ENLV&p=W&b=5&g=0&id=p86431144783
      👍️0
      glenn1919 glenn1919 5 months ago
      ENLV.........................................https://stockcharts.com/h-sc/ui?s=ENLV&p=W&b=5&g=0&id=p86431144783
      👍️0
      Monksdream Monksdream 10 months ago
      ENLV under $4
      👍️0
      TrendTrade2016 TrendTrade2016 11 months ago
      ENLV...NEXT BIO BEAST READY TO break out
      👍️0
      MOCKBA MOCKBA 6 years ago
      I see ok, they should send a PR about it!
      👍️0
      dinogreeves dinogreeves 6 years ago
      I mean that ENLV is now Nasdaq compliant, there are no issues with Nasdaq on their filings,
      👍️0
      MOCKBA MOCKBA 6 years ago
      What you mean by that?
      👍️0
      dinogreeves dinogreeves 6 years ago
      ENLV Nasdaq compliant now, should get a press release soon.
      👍️0
      dinogreeves dinogreeves 6 years ago
      checkout website you'll be impressed

      https://www.enlivex.com
      👍️0
      MOCKBA MOCKBA 6 years ago
      Dino, grabbed a small position, looks very intriguing to say the least
      👍️0
      dinogreeves dinogreeves 6 years ago
      They have over 35 million in cash man, no dilution for at least 2 years. Buy ENLV with everything you got.
      👍️0
      dinogreeves dinogreeves 6 years ago
      This is ENLV now, buy all you can, they reverse merged with ORPN
      👍️0
      dinogreeves dinogreeves 6 years ago
      This is one the best bios out there, soon to surpass what BPTH did
      👍️0
      whytestocks whytestocks 6 years ago
      News: $ORPN Bioblast Announces Effectiveness of Eight to One Reverse Split

      Tel Aviv, Israel, March 06, 2019 (GLOBE NEWSWIRE) -- Bioblast Pharma Ltd. (NasdaqCM: ORPN), a clinical-stage, orphan disease-focused biotechnology company, announced the effectiveness of an eight to one reverse split of its share capital. As previously reported, the reverse split was approv...

      Find out more https://marketwirenews.com/news-releases/bioblast-announces-effectiveness-of-eight-to-one-reverse-split-7810132.html
      👍️0
      ClayTrader ClayTrader 6 years ago
      * * $ORPN Video Chart 02-19-2019 * *

      Link to Video - click here to watch the technical chart video

      👍️0
      ClayTrader ClayTrader 6 years ago
      * * $ORPN Video Chart 11-20-18 * *

      Link to Video - click here to watch the technical chart video

      👍️0
      r1aviator r1aviator 6 years ago
      $ORPN

      Bioblast Pharma Ltd. Announces Entry Into Merger Agreement to Acquire Enlivex Therapeutics Ltd. to Advance Clinical Stage Immunotherapeutic Drug Pipeline for the Treatment of Life-Threatening Diseases Sepsis, GvHD and Solid Tumors

      https://twitter.com/birdseyepix/status/1064655592529117184?s=21
      👍️0
      r1aviator r1aviator 6 years ago
      Running :)

      $ORPN
      👍️0
      r1aviator r1aviator 6 years ago
      Took a starter

      $ORPN
      👍️0
      ClayTrader ClayTrader 7 years ago
      * * $AXXA Video Chart 05-18-18 * *

      Link to Video - click here to watch the technical chart video

      👍️0
      ClayTrader ClayTrader 7 years ago
      * * $SDRL Video Chart 05-18-18 * *

      Link to Video - click here to watch the technical chart video

      👍️0
      ClayTrader ClayTrader 7 years ago
      * * $ORPN Video Chart 05-18-18 * *

      Link to Video - click here to watch the technical chart video

      👍️0
      europtiger europtiger 7 years ago
      Crazy downer but buying more 3,10 as i belive Shorts will bien there Fingers
      👍️0
      europtiger europtiger 7 years ago
      Looking good

      Nice bids coming in

      👍️0
      crudeoil24 crudeoil24 7 years ago
      Very nice call! Blast off > Blast Pharma! orpn
      👍️0
      europtiger europtiger 7 years ago
      Here we Go
      👍️0
      europtiger europtiger 7 years ago
      Yep float has been traded allready

      Hope for breakout just bought more

      But stop is in
      👍️0
      crudeoil24 crudeoil24 7 years ago
      Traders running this low floater > Brooklyn!
      👍️0
      europtiger europtiger 7 years ago
      Got 2,90‘s
      👍️0
      Golden Cross Golden Cross 7 years ago
      ORPN cheat sheet:

      https://www.barchart.com/stocks/quotes/ORPN/cheat-sheet
      👍️0
      Golden Cross Golden Cross 7 years ago
      Short squeeze info:


      http://shortsqueeze.com/?symbol=orpn&submit=Short+Quote%E2%84%A2
      👍️0
      Golden Cross Golden Cross 7 years ago
      MACD looking bullish
      👍️0
      Golden Cross Golden Cross 7 years ago
      Chart shaping up:

      👍️0
      DewDiligence DewDiligence 7 years ago
      Caveat emptor! This looks like a financing deal is coming soon.
      👍️0
      europtiger europtiger 7 years ago
      Running hard

      Super Low Float
      👍️0
      Me stocks Me stocks 7 years ago
      This one is investment. It will go to 15$ at least in 2018.
      👍️0
      Awl416 Awl416 7 years ago
      That was fast
      👍️0
      DewDiligence DewDiligence 7 years ago
      ORPN 9/30/17 cash=$4.1M (down from $5.2M at 6/30/17):

      https://finance.yahoo.com/news/bioblast-pharma-reports-third-quarter-113000168.html
      👍️0
      DewDiligence DewDiligence 7 years ago
      1:5 reverse split is effective today (eom).
      👍️0
      DewDiligence DewDiligence 7 years ago
      ORPN implements 1:5 reverse split effective on date to be announced:

      https://www.sec.gov/Archives/edgar/data/1596812/000114420417048497/v475345_6k.htm
      👍️0
      jcbaby jcbaby 7 years ago
      you are correct this play could rise very very fast
      👍️0
      theprofit444 theprofit444 7 years ago
      its a revised outlook lmaooooo
      👍️0
      jcbaby jcbaby 7 years ago
      didn't you say 10 awhile back lol lets hope for anything but its current price
      👍️0
      theprofit444 theprofit444 7 years ago
      itll be 4 dollars a share by yr end
      👍️0
      DewDiligence DewDiligence 8 years ago
      ORPN 2Q17 PR:

      https://www.sec.gov/Archives/edgar/data/1596812/000114420417040598/v472433_ex99-1.htm

      6/30/17 cash was $5.2M.
      👍️0
      jcbaby jcbaby 8 years ago
      this could rocket over a dollar in a swift blow got to be ready
      👍️0
      DewDiligence DewDiligence 8 years ago
      Two months has elapsed since the post I'm replying to. They'd better come up with a plan soon.
      👍️0
      stocktrademan stocktrademan 8 years ago
      ORPN buy 0.656

      inverted head and shoulders bottom
      bullish divergence breakout and initial pullback level
      high volume on advances, lower volume on retracements indicates strong demand for the stock
      pennant breakout soon
      breaking out over the ichimoku cloud
      moving average golden cross pattern









      normal chart




      log chart



      👍️0
      jcbaby jcbaby 8 years ago
      should be an interesting day for this stock will see?
      👍️0

      Your Recent History

      NASDAQ
      ENLV
      Enlivex Therapeutics
      BIT
      UB7RXG
      Unicredit Bank
      Delayed Upgrade Clock

      Go Ad-Free

      Subscribe to Ad free and enjoy an ad-free experience

      No Ads

      Try Now

      Keep the Ads